4712results about "Flow monitors" patented technology

An auto-occlusion safety device is provided for use in preventing rupture of infusion components during rapid infusion procedures. An occlusion valve is disclosed having a threshold pressure that is less than a rupture tolerance of the infusion system components. As the fluid pressure of the infusion system increases beyond the threshold pressure of the occlusion valve, the occlusion valve is automatically activated thereby occluding fluid flow upstream from a vulnerable infusion component. An accumulator is further disclosed for use in combination with the safety device to compensate for time delays in full activation of the occlusion valve.

The invention provides a field intelligent injection pump automatic control method and system based on physiological parameter monitoring, and relates to the technical field of automatic control. The physiological parameter information is input into an intelligent decision module, a personalized drug administration scheme is generated based on a reinforcement learning algorithm in combination with a physiological function state report and a drug action mechanism knowledge base, and the personalized drug administration scheme comprises a drug ratio, an injection rate and an injection time sequence; the personalized administration scheme is sent to the intelligent injection module, and the injection step is executed; the energy management unit performs energy collection and storage through a flexible photovoltaic film and a phase change energy storage material, establishes a multi-objective optimization function based on drug storage conditions and environmental parameters, and performs intelligent distribution and adaptive adjustment on the power consumption of the injection pump system; the state of the injection pump pipeline is evaluated based on multi-mode sensing information, dynamic safety evaluation is conducted in combination with real-time physiological monitoring, and graded protection is triggered.

One embodiment of the present disclosure relates to drug injector monitoring method and device and provides drug injector monitoring method and device that monitor a battery state, a remaining drug amount, temperature, and pressure of a drug injector such that a fixed amount of drug may be stably injected.

Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and / or fully automated.

The present invention relates to a movement disorder monitor, and a method of measuring the severity of a subject's movement disorder. The present invention additionally relates to a treatment delivery system for treating a subject in response to changes in the severity of a subject's symptoms. The present invention further provides for a system and method, which can accurately quantify symptoms of movement disorders, utilizing continuously obtained kinetic information to be analyzed, accurately distinguishing between symptoms of movement disorders and activities of daily living, relating quantified symptoms to a standard clinical rating scale, and correlating a subject's symptoms with certain physiological and environmental factors. The present invention still further provides for home monitoring of symptoms in subjects with these movement disorders in order to capture the complex fluctuation patterns of the disease over the course of days, weeks, months, or years.

A fluidics system includes a cassette having a saline subsystem, a contrast subsystem, and a vacuum subsystem. The fluidics system further includes a splitter and a first tubing set coupled to the cassette and splitter, the first tubing set having a single saline channel, a single contrast channel, and a single vacuum channel. The fluidics system further includes two or more hub assemblies, at least one of the two or more hub assemblies configured to have a third saline flow-path, a third contrast flow-path, and a third vacuum flow-path to provide saline, contrast and vacuum to the lumen of a catheter coupled to the at least one of the two or more hub assemblies. The fluidics system further includes a second tubing set having a plurality of tube groups, each tube group coupled to the splitter and to one of the two or more hub assemblies.

Devices and methods to mitigate the erroneous signal imparted by physical and / or chemical process incident upon analyte-selective electrochemical sensors that are non-analyte-related in origin are disclosed herein. A sensing system featuring at least one of an analyte-selective sensor and at least one of an analyte-invariant sensor.

The invention provides an intelligent anesthesia depth monitoring method and system. A plurality of physiological parameter sensors are used for synchronously collecting composite physiological signals of a patient, and meanwhile brain wave signals of the patient in the anesthesia process are obtained; analyzing and processing the anesthesia state by fusing an electroencephalogram spectrum analysis algorithm and a nonlinear kinetic model to obtain a consciousness state map of anesthesia depth and consciousness edge fluctuation; performing real-time evaluation on the current anesthesia depth by using an adaptive threshold algorithm in combination with a Bayesian reasoning framework, and performing prediction processing on the trend change of the anesthesia depth in a future short time by using a long-short term memory neural network to obtain an evaluation result and a prediction trend; the anesthetic infusion rate is automatically adjusted so as to maintain the ideal anesthesia depth, meanwhile, potential risks are subjected to intelligent grading early warning processing, and an anesthesia management strategy is generated. According to the technical scheme provided by the invention, the safety and personalized management level of the anesthesia process are improved.

Embodiments relate to device, system and methods for personalised drug dosing via a device, the device comprising a first chamber comprising a drug reservoir unit; a second chamber comprising an electronic unit comprising a control component; a third chamber comprising a drug delivery unit and a flow control component controlled via the electronic unit; wherein the device is fully implanted in a subject during its intended operational modes, and wherein the device releases a body temperature stable drug formulation into the subject at a flow rate such that a variation in the flow rate is within ±15% by volume.

The invention relates to the technical field of medical equipment, and discloses a multi-head transfusion intelligent switching control system, which comprises the following modules interconnected with a control bus through a data bus: a multi-source information binding module; a multi-modal sensing data fusion module; an intelligent safety control module; an edge-cloud collaborative decision module; a human factor engineering interaction module; a system full life cycle management module; and an infusion pipeline switching execution mechanism. Through the multi-mode sensing fusion and real-time data processing technology, the whole-course automatic monitoring of the infusion progress, the flow speed and the remaining medicine amount is achieved. The nurse station central billboard and the mobile terminal synchronously display infusion states of all beds, sound-light alarm is triggered in time when abnormal conditions occur, manual patrol video frequency is remarkably reduced, an edge computing node is applied to carry out localized data analysis, and it is ensured that alarm response delay is lower than a clinical safety threshold value. And the problem of low efficiency caused by manual regular patrol traditionally is effectively solved.

Systems and methods implement algorithms for initializing medical devices, including by programming initial medical device settings. Further, systems and methods implement adaptive algorithms for changing medical device settings. Settings initialization algorithms can calculate the settings most likely to be applicable for the patient at-issue using databases of positive clinical outcomes and respective therapy settings for existing users. Settings adaptation algorithm are configured to update medical device therapy settings at one or more intervals including based on databases of positive clinical outcomes and respective therapy settings for existing users.

A modular disease management system may provide medication management for a patient. The system may include a base configured to at least partially couple to a tissue site of a patient. The system may further include a medication bladder coupled to the base and configured to maintain medication. The system may further include a medication pump coupled to the medication bladder, comprising a conduit and muscle wire-actuated plungers, wherein the medication pump is configured to cause the medication to flow from the medication bladder through the conduit. The system may further include a cannula insertion device coupled to the medication pump via the conduit, wherein the cannula insertion device comprises a cannula, a spring, and a triggering component, wherein the cannula insertion device is configured to insert the cannula into the tissue site of the patient by actuation of the spring released by the triggering component.

An injection device comprises: a carrier; a needle; a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration; a shuttle configured to move the driver between the retracted configuration and the deployed configuration; and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.

An infusion pump system and method with common line auto flush, wherein the infusion pump system has a first reservoir, a second reservoir, a junction, a common line having one end in fluid connection with the junction and having a terminal fluid delivery end, and an infusion pump. The method includes infusing the first fluid at a first rate along a first flow path; entering a common line flush volume value for the common line; switching from the first flow path to a second flow path; driving the second fluid at the first rate along the second flow path; monitoring volume of the second fluid driven at the first rate; and driving the second fluid at a second rate along the second flow path when the monitored volume is equal to or greater than the common line flush volume value.

The invention discloses an intelligent infusion monitoring management system, and relates to the technical field of medical equipment, and the system comprises the steps: collecting patient data, synchronizing the patient data to a central monitoring system through a block chain technology, and generating a personalized infusion scheme; based on a personalized infusion scheme, a medical worker uses a mobile device to carry out identity verification on a patient and obtain medicine information, and a voice assistant function is integrated; the monitoring module is responsible for monitoring vital signs of a patient and the temperature of a ward by using wearable equipment and a temperature sensor, and adjusting a personalized infusion scheme and liquid temperature according to the vital signs and the temperature of the ward; the risk value prediction module is responsible for predicting risk values of blockage and leakage according to the adjusted personalized infusion scheme and the liquid temperature and setting a graded alarm mechanism; patients and family members receive the infusion progress through the intelligent infusion monitor. According to the invention, the block chain technology and the advanced artificial intelligence algorithm are integrated, so that the health data and medicine information of the patient can be efficiently managed and analyzed.

The invention discloses a peripheral vein puncture blood vessel pressure monitoring system for image enhancement examination based on multi-modal fusion, and relates to the technical field of medical image assistion.The peripheral vein puncture blood vessel pressure monitoring system comprises the steps that image data, sensor data and personalized data of a patient are collected; generating an image feature vector, a sensor feature vector and a personalized feature vector based on the preprocessed multi-modal data, carrying out feature interaction on a multi-modal feature line, carrying out representation fusion by combining Transform with contrast learning, and generating a fusion representation vector; the maximum tolerance pressure, the extravasation risk level and the recommended injection flow rate range of the target puncture point under the current injection flow rate are predicted and evaluated in the blood vessel pressure resistance prediction model, injection suggestions and injection alarms of the target puncture point are generated, and injection parameters are automatically adjusted. According to the method, the personalized safety pressure threshold values of patients with different blood vessel conditions are accurately evaluated, and the safety and accuracy of peripheral vein puncture are remarkably improved.

The invention relates to the technical field of medical monitoring, and discloses a novel infusion alarm and an infusion alarm system. The system comprises an infusion state monitoring module, an alarm decision module and an alarm execution module. A multi-source sensing unit of the infusion state monitoring module is distributed in a liquid level detection area, a drip chamber area and a patient contact area of an infusion tube assembly and collects optical refractive index, gravity change and real-time image data, and a data fusion unit performs heterogeneous signal fusion on the data to generate a multi-mode infusion state signal. A state analysis unit of the alarm decision module receives the signal and outputs a liquid level prediction signal and an infusion abnormal risk signal, and an alarm rule engine generates an alarm trigger threshold according to the signal. And a sound-light alarm unit of the alarm execution module responds to the threshold value to start a sound-light alarm sequence, a remote notification unit generates a graded alarm notification based on the abnormal risk signal, and a man-machine interaction interface outputs a comprehensive risk index.

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and / or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

To provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue.SOLUTION: In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion or a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and / or energy are effective in injuring or damaging tissue, nerves and nerve endings in order to relieve disease symptoms.SELECTED DRAWING: Figure 3B

A system and a method provide closed-loop sedation, anesthesia, or analgesia by monitoring EEG and automatically adjusting delivery of sedative, anesthetic, and / or analgesic drugs to maintain a desired or predetermined level of cortical at all echelons of care. The system and the method further monitor a subject's cortical activity to detect occurrence of burst suppression which can be indicative of unsafe depth of anesthesia or sedation. Further, the system and the method provide for alteration or cessation of administration of anesthesia or sedation based on the occurrence of burst suppression to mitigate harm to the subject.

This disclosure generally relates to medical devices that include a sensor transmitter assembly that includes a sensor assembly including a sensor module where a first sensor including a first sensor head having at least one first sensor contact pad is combined with a second sensor including a second sensor head having at least one second sensor contact pad. The sensor transmitter assembly also includes a transmitter assembly positioned on a top of the sensor assembly to form a single unit, the transmitter assembly having at least one transmitter contact disposed on a base of the transmitter assembly, where the first sensor contact pad(s) and the second sensor form a connection path with the transmitter contact(s).

A system and method to configure a rule set used in connection with a medical monitoring system for monitoring patients and patient care equipment, especially medication delivery pumps, based on a variety of conditions and parameters associated with monitored biometric information and equipment information and for providing user-defined responses to those conditions and parameters.

A fluidics system includes a cassette having a saline subsystem, a contrast subsystem, and a vacuum subsystem. The fluidics system further includes a splitter and a first tubing set coupled to the cassette and splitter, the first tubing set having a single saline channel, a single contrast channel, and a single vacuum channel. The fluidics system further includes two or more hub assemblies, at least one of the two or more hub assemblies configured to have a third saline flow-path, a third contrast flow-path, and a third vacuum flow-path to provide saline, contrast and vacuum to the lumen of a catheter coupled to the at least one of the two or more hub assemblies. The fluidics system further includes a second tubing set having a plurality of tube groups, each tube group coupled to the splitter and to one of the two or more hub assemblies.

To provide a formulation for treating at least one of hypertension, pulmonary hypertension, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of the formulation to a tissue.SOLUTION: In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion and a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and / or energy are effective to injure or damage tissues, nerves and nerve endings in order to relieve disease symptoms.SELECTED DRAWING: None

A method, computer program product, and computer system for a cloud-based medication tracking system. The system may include a plurality of intelligent injection devices across multiple healthcare facilities, each having: a barrel in fluid communication with a needle, a piston including a plunger, a microprocessor, a wireless communication module a supply chain tracking system configured to: monitor distribution of an injectable medication, verify availability of the injectable medication, track a global medication delivery pattern relating to the injectable medication, a machine learning system trained to: analyze medication usage data across healthcare entities, predict a supply chain event, optimize an inventory level, and improve a distribution datum.

Systems and methods for providing recommended doses and instructions for pharmaceutical treatments, and more particularly systems and methods for measuring physiological and / or electrophysiological signals from a subject and providing recommended doses and instructions of pharmaceuticals based at least in part on the measured signals are described. Further, the recommended doses and instructions are based at least in part on a subject's disease(s), disorder(s), or injuries and / or symptom(s) of such, and / or side effects of medications or treatments the subject is receiving. The recommended doses and instructions are personally tailored to the subject to precisely and personally address the subject's needs, and may be based in part on correlation with database(s) comprising historical data of the subject and / or other subjects to treat the subject's movement disorders, injuries to the body or brain, cognitive diseases and disorders, sleep diseases and disorders, chronic pain, or other conditions.

The invention provides an intelligent infusion monitoring method and system based on multi-sensor fusion, and relates to the technical field of intelligent infusion monitoring. The method comprises the following steps: acquiring infusion process data through a visual sensor, a weight sensor and an infrared sensor; aligning the time sequence labels and synchronously generating a fusion data stream; extracting a liquid level height characteristic, a weight change rate and a real-time dripping speed value, and carrying out dynamic weighting calculation; acquiring infusion doctor's advice data of a hospital information system, and extracting a preset dripping speed range and a total liquid amount; calculating the residual infusion time based on the weighted data and the total liquid amount correlation; when the weighted real-time dripping speed value deviates from a preset range, the weighted weight change rate is not matched with the liquid level height trend or the dripping speed pulse signal is lost, an early warning instruction is generated; and the remaining time and the early warning state are visually displayed at the nurse station terminal. Through multi-source data fusion and cross validation, the problems of incomplete monitoring, time sequence dislocation and early warning lag are solved, and infusion safety and management efficiency are improved.

A system to configure a neurostimulation signal to a patient's body has a neurostimulator to create a base stimulation signal which has a series of first pulses. A computer processor within the neurostimulator deconstructs the first series of pulses into a first and second partial pulse series which have respective first and second partial electrical pulses where the first and second partial electrical pulses substantially summate to the base stimulation signal. A programmable signal generator provides a constant amplitude of combined stimulation pulses by applying the first and second partial pulses to a number of contacts of an electrode positionally located to stimulate a target tissue in the patient's body.

The invention relates to the technical field of medical treatment, in particular to a multi-parameter collaborative infusion process intelligent monitoring and priority calling method, which comprises the following steps of: acquiring four-dimensional monitoring data through a liquid level pressure sensor array, an infrared dripping speed detection module, a flexible temperature patch and a photoelectric heart rate sensor, and combining an LSTM (Long Short Term Memory) anomaly prediction model, and outputting the pipeline state score, the allergy risk index and the infusion progress prediction value in real time. And generating a real-time risk value through a weight configuration mechanism and stage identification logic, judging a risk level according to a dynamic threshold value, and outputting a corresponding early warning level signal. And the system further maps the early warning level signals into common, emergency and critical call instructions, and distributes the common, emergency and critical call instructions to a multi-channel execution terminal to construct a multi-level linkage response mechanism of closed-loop feedback. According to the invention, the accuracy and response efficiency of infusion risk identification can be significantly improved, and the method is suitable for intelligent reconstruction and automatic early warning response scenes of a clinical nursing information system.